Home › Compare › CFEGF vs JNJ

CFEGF vs JNJ: Dividend Comparison 2026

CFEGF yields 26666.67% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CFEGF wins by $915008218858322657280.00M in total portfolio value
10 years
CFEGF
CFEGF
● Live price
26666.67%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$915008218858322657280.00M
Annual income
$908,307,797,917,658,400,000,000,000.00
Full CFEGF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CFEGF vs JNJ

📍 CFEGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCFEGFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CFEGF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CFEGF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CFEGF
Annual income on $10K today (after 15% tax)
$2,266,666.67/yr
After 10yr DRIP, annual income (after tax)
$772,061,628,230,009,600,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CFEGF beats the other by $772,061,628,230,009,600,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CFEGF + JNJ for your $10,000?

CFEGF: 50%JNJ: 50%
100% JNJ50/50100% CFEGF
Portfolio after 10yr
$457504109429161328640.00M
Annual income
$454,153,898,958,829,200,000,000,000.00/yr
Blended yield
99.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CFEGF
No analyst data
Altman Z
-9.8
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CFEGF buys
0
JNJ buys
0
No recent congressional trades found for CFEGF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCFEGFJNJ
Forward yield26666.67% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$915008218858322657280.00M ✓$20.0K
Annual income after 10y$908,307,797,917,658,400,000,000,000.00 ✓$827.78
Total dividends collected$914567051678776164352.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CFEGF vs JNJ ($10,000, DRIP)

YearCFEGF PortfolioCFEGF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$2,677,367$2,666,666.67$10,676$355.77+$2.67M → CFEGF
2$670,121,272$667,256,490.13$11,407$389.39+$670.11M → CFEGF
3$156,799,662,298$156,082,632,536.95$12,198$426.53+$156799.65M → CFEGF
4$34,299,837,353,716$34,132,061,715,056.25$13,056$467.62+$34299837.34M → CFEGF
5$7,014,615,943,610,743$6,977,915,117,642,268.00$13,987$513.12+$7014615943.60M → CFEGF
6$1,341,192,098,307,730,000$1,333,686,459,248,066,600.00$14,998$563.56+$1341192098307.71M → CFEGF
7$239,753,188,972,257,800,000$238,318,113,427,068,550,000.00$16,098$619.52+$239753188972257.81M → CFEGF
8$40,071,532,325,128,600,000,000$39,814,996,412,928,290,000,000.00$17,295$681.69+$40071532325128600.00M → CFEGF
9$6,262,075,645,480,441,000,000,000$6,219,199,105,892,554,000,000,000.00$18,599$750.82+$6262075645480440832.00M → CFEGF
10$915,008,218,858,322,600,000,000,000$908,307,797,917,658,400,000,000,000.00$20,022$827.78+$915008218858322657280.00M → CFEGF

CFEGF vs JNJ: Complete Analysis 2026

CFEGF — Stock

China Nonferrous Gold Limited engages in exploration, mine development, and mining activities in the Cayman Islands. It primarily holds a 100% interest in the Pakrut gold project located in the southern Tien-Shan Fold belt, Tajikistan. The company was formerly known as Kryso Resources Corporation Limited and changed its name to China Nonferrous Gold Limited in October 2013. The company was incorporated in 2013 and is based in Grand Cayman, Cayman Islands. China Nonferrous Gold Limited operates as a subsidiary of China Nonferrous Metals Mining (Group) Co. Limited.

Full CFEGF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CFEGF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CFEGF vs SCHDCFEGF vs JEPICFEGF vs OCFEGF vs KOCFEGF vs MAINCFEGF vs ABBVCFEGF vs MRKCFEGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.